%0 Figure %A Hall, Michaela T. %A Simms, Kate T. %A Lew, Jie-Bin %A A. Smith, Megan %A Saville, Marion %A Canfell, Karen %D 2018 %T Predicted age standardised rates (ASR) for: (a) CIN2/3 per 1,000 women, (b) cervical cancer diagnosis per 100,000 women and (c) cervical cancer mortality per 100,000 women; base case scenario shown. %U https://plos.figshare.com/articles/figure/Predicted_age_standardised_rates_ASR_for_a_CIN2_3_per_1_000_women_b_cervical_cancer_diagnosis_per_100_000_women_and_c_cervical_cancer_mortality_per_100_000_women_base_case_scenario_shown_/5887438 %R 10.1371/journal.pone.0185332.g002 %2 https://plos.figshare.com/ndownloader/files/10488295 %K population level %K Conclusions Transient increases %K HPV screening %K Findings Transient increases %K cancer rates %K cancer incidence %K HPV test accuracy %K 2017 rates %K Cervical cancer mortality rates %K December 2017. Methods %K CIN %K HPV vaccination %K longer-interval HPV screening %X

*Ages considered are 0–84 years; age standardised rates are standardised to the Australian Bureau of Statistics 2001 ‘Series B’ population estimates.

%I PLOS ONE